Canopy Growth (CGC) Amortizatization of Intangibles (2019 - 2025)
Canopy Growth's (CGC) quarterly Amortizatization of Intangibles came in at $3.0 million in Q4 2025, down 22.52% year-on-year from $3.8 million in Q4 2024, and down 8.23% quarter-over-quarter from $3.2 million in Q3 2025.
Canopy Growth (CGC) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Amortizatization of Intangibles across 7 years of filings, most recently posting $3.0 million for Q4 2025.
- Amortizatization of Intangibles for Q4 2025 came in at $3.0 million, down 22.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $13.6 million (down 13.21% YoY), and the FY2025 annual result was $15.1 million, down 18.22% from the prior year.
- Amortizatization of Intangibles came in at $3.0 million for Q4 2025 at Canopy Growth, down from $3.2 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $10.0 million in Q1 2021 to a low of $9697.1 in Q3 2023.
- The 5-year median for Amortizatization of Intangibles is $4.0 million (2024), against an average of $4.3 million.
- Across the five-year window, Amortizatization of Intangibles slumped 99.86% in 2022 and surged 40335.84% in 2024, its largest moves.
- Canopy Growth's Amortizatization of Intangibles stood at $8.4 million in 2021, then slumped by 99.86% to $11787.2 in 2022, then jumped by 39221.47% to $4.6 million in 2023, then dropped by 17.11% to $3.8 million in 2024, then declined by 22.52% to $3.0 million in 2025.
- The last three Amortizatization of Intangibles figures came in at $3.0 million (Q4 2025), $3.2 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 242,000.00 |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | 2.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.98 Mn |
| Dec 31, 2025 | 2.98 Mn |
| Sep 30, 2025 | 3.24 Mn |
| Sep 30, 2025 | 3.24 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 3.84 Mn |
| Mar 31, 2025 | 3.84 Mn |
| Dec 31, 2024 | 3.84 Mn |
| Dec 31, 2024 | 3.84 Mn |
| Sep 30, 2024 | 3.92 Mn |
| Sep 30, 2024 | 3.92 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Dec 31, 2023 | 4.63 Mn |
| Dec 31, 2023 | 4.63 Mn |
| Sep 30, 2023 | 9,697.10 |
| Sep 30, 2023 | 9,697.10 |